140 related articles for article (PubMed ID: 12412834)
1. Effects of smoked marijuana in healthy and HIV + marijuana smokers.
Haney M
J Clin Pharmacol; 2002 Nov; 42(S1):34S-40S. PubMed ID: 12412834
[TBL] [Abstract][Full Text] [Related]
2. Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
[TBL] [Abstract][Full Text] [Related]
3. Bupropion SR worsens mood during marijuana withdrawal in humans.
Haney M; Ward AS; Comer SD; Hart CL; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 May; 155(2):171-9. PubMed ID: 11401006
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone decreases anxiety during marijuana withdrawal in humans.
Haney M; Hart CL; Ward AS; Foltin RW
Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
[TBL] [Abstract][Full Text] [Related]
5. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
Haney M; Rabkin J; Gunderson E; Foltin RW
Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
[TBL] [Abstract][Full Text] [Related]
6. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
7. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
[TBL] [Abstract][Full Text] [Related]
8. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
[TBL] [Abstract][Full Text] [Related]
9. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.
Haney M; Gunderson EW; Rabkin J; Hart CL; Vosburg SK; Comer SD; Foltin RW
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):545-54. PubMed ID: 17589370
[TBL] [Abstract][Full Text] [Related]
10. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
11. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
12. Abstinence symptoms following smoked marijuana in humans.
Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 1999 Feb; 141(4):395-404. PubMed ID: 10090647
[TBL] [Abstract][Full Text] [Related]
13. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral THC maintenance on smoked marijuana self-administration.
Hart CL; Haney M; Ward AS; Fischman MW; Foltin RW
Drug Alcohol Depend; 2002 Aug; 67(3):301-9. PubMed ID: 12127201
[TBL] [Abstract][Full Text] [Related]
15. Abstinence symptoms following oral THC administration to humans.
Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 1999 Feb; 141(4):385-94. PubMed ID: 10090646
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.
Bedi G; Foltin RW; Gunderson EW; Rabkin J; Hart CL; Comer SD; Vosburg SK; Haney M
Psychopharmacology (Berl); 2010 Dec; 212(4):675-86. PubMed ID: 20824270
[TBL] [Abstract][Full Text] [Related]
17. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
[TBL] [Abstract][Full Text] [Related]
18. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Cooper ZD; Foltin RW
Psychopharmacology (Berl); 2010 Aug; 211(2):233-44. PubMed ID: 20521030
[TBL] [Abstract][Full Text] [Related]
19. A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.
Carpenter KM; McDowell D; Brooks DJ; Cheng WY; Levin FR
Am J Addict; 2009; 18(1):53-64. PubMed ID: 19219666
[TBL] [Abstract][Full Text] [Related]
20. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.
Vandrey R; Stitzer ML; Mintzer MZ; Huestis MA; Murray JA; Lee D
Drug Alcohol Depend; 2013 Feb; 128(1-2):64-70. PubMed ID: 22921474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]